Search

everythinglearnresearchcommunity

for

Search:↓

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Plant-based medicines can effectively prevent and treat cancer with fewer side effects.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

New standards were created to make chemotherapy safer and improve cancer care.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

The Ganoderma mushroom has many health benefits, including anti-cancer properties.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Microneedles improve delivery of plant-based compounds through the skin, aiding treatments for hair loss, cancer, and wounds.